These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8131019)

  • 1. Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co-Operative Urological Group.
    Kiemeney LA; Witjes JA; Heijbroek RP; Koper NP; Verbeek AL; Debruyne FM
    Br J Urol; 1994 Feb; 73(2):164-71. PubMed ID: 8131019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer.
    Kiemeney LA; Witjes JA; Heijbroek RP; Debruyne FM; Verbeek AL
    Eur J Cancer; 1994; 30A(11):1621-5. PubMed ID: 7833133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
    Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
    Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of urothelial dysplasia concomitant with superficial bladder cancer].
    Ishii T; Takeuchi F; Hiratsuka Y; Ariyoshi A
    Nihon Hinyokika Gakkai Zasshi; 1999 Jun; 90(6):633-8. PubMed ID: 10422439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of bladder biopsies with TUR-BT according to cytology results in patients with bladder cancer: a case control study.
    Matsushima M; Kikuchi E; Hasegawa M; Matsumoto K; Miyajima A; Oya M
    BMC Urol; 2010 Jun; 10():12. PubMed ID: 20591189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Random biopsy and recurrence risk in patients with bladder cancer].
    Yamada Y; Hayashi Y; Kohri K; Terao E; Hirao N; HoriH ; IwaiY ; Kato K; Ito T; Tawada T; Asaka H; Andou H; Kawai T; Ikeuchi T; Watanabe H
    Nihon Hinyokika Gakkai Zasshi; 1996 Jan; 87(1):61-6. PubMed ID: 8683895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in pTa-pT1 superficial bladder tumours treated with intravesical instillations. The Dutch South-Eastern Urological Collaborative Group.
    Mulders PF; Meyden AP; Doesburg WH; Oosterhof GO; Debruyne FM
    Br J Urol; 1994 Apr; 73(4):403-8. PubMed ID: 8199828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical instillation of epirubicin: effect on tumour recurrence in patients with dysplastic epithelium after transurethral resection of superficial bladder tumour.
    Igawa M; Urakami S; Shirakawa H; Shiina H; Ishibe T; Kadena H; Usui T; Kawanishi M
    Br J Urol; 1996 Mar; 77(3):358-62. PubMed ID: 8814838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
    Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis and treatment of T1G3 bladder tumours. A prognostic factor analysis of 121 patients. Dutch South Eastern Bladder Cancer Study Group.
    Mulders PF; Hoekstra WJ; Heybroek RP; Schapers ER; Verbeek AL; Oosterhof GO; Debruyne FM
    Eur J Cancer; 1994; 30A(7):914-7. PubMed ID: 7946582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of random bladder biopsies in superficial bladder cancer.
    Göğüş C; Bedük Y; Türkölmez K; Göğüs O
    Int Urol Nephrol; 2002; 34(1):59-61. PubMed ID: 12549641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group.
    Kiemeney LA; Witjes JA; Verbeek AL; Heijbroek RP; Debruyne FM
    Br J Cancer; 1993 Apr; 67(4):806-12. PubMed ID: 8471440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-a2b reduces neo-microvascular density in the 'normal' urothelium adjacent to the tumor after transurethral resection of superficial bladder carcinoma.
    Giannopoulos A; Adamakis I; Evangelou K; Giannopoulou M; Zacharatos P; Zsantoulis P; Perunovic B; Athanasiou A; Retalis G; Constandinidis C; Gorgoulis VG
    Onkologie; 2003 Apr; 26(2):147-52. PubMed ID: 12771523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [pT1G3 tumor of the bladder].
    Vicini D; Bettaglio G; Dallera P; Ruggieri M; Mirando P; Franceschetti GP; Sali C; Picchio GL
    Arch Ital Urol Androl; 1996 Feb; 68(1):61-5. PubMed ID: 8664925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of bladder quadrant biopsies in patients with primary superficial bladder carcinoma.
    Flamm J; Dona S
    Eur Urol; 1989; 16(2):81-5. PubMed ID: 2714336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of expected treatment outcomes, obtained using risk models and international guidelines, with observed treatment outcomes in a Dutch cohort of patients with non-muscle-invasive bladder cancer treated with intravesical chemotherapy.
    Lammers RJ; Palou J; Witjes WP; Janzing-Pastors MH; Caris CT; Witjes JA
    BJU Int; 2014 Aug; 114(2):193-201. PubMed ID: 24304638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer.
    Kiemeney LA; Witjes JA; Heijbroek RP; Verbeek AL; Debruyne FM
    J Urol; 1993 Jul; 150(1):60-4. PubMed ID: 8510276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation of biopsies of "normal" urothelium in patients with superficial bladder cancer. MRC Superficial Bladder Cancer Sub Group.
    Richards B; Parmar MK; Anderson CK; Ansell ID; Grigor K; Hall RR; Morley AR; Mostofi FK; Risdon RA; Uscinska BM
    Br J Urol; 1991 Apr; 67(4):369-75. PubMed ID: 2032076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [pT1G3 bladder carcinoma: parameters of a correct therapy].
    Ruoppolo M; Dell'Orto P; Fenice O; Seveso M; Ferri P; Zaatar C; Tagliaferri A; Cogni M; Bellorofonte G; Tombolini P
    Arch Ital Urol Androl; 1996 Feb; 68(1):17-20. PubMed ID: 8664914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.